Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6TDF

Crystal structure of Aspergillus fumigatus Glucosamine-6-phosphate N-acetyltransferase 1 in complex with compound 3

Summary for 6TDF
Entry DOI10.2210/pdb6tdf/pdb
DescriptorGlucosamine 6-phosphate N-acetyltransferase, ACETYL COENZYME *A, 2-[[3,5-bis(chloranyl)-4-(4~{H}-1,2,4-triazol-3-yl)phenyl]-(2-hydroxyethyl)amino]ethanol, ... (5 entities in total)
Functional Keywordsfragment screening, anti fungal, aspergillus fumigatus, inhibitor, transferase
Biological sourceAspergillus fumigatus Af293
Total number of polymer chains1
Total formula weight22512.99
Authors
Raimi, O.G.,Stanley, M.,Lockhart, D. (deposition date: 2019-11-08, release date: 2020-04-29, Last modification date: 2024-01-24)
Primary citationLockhart, D.E.A.,Stanley, M.,Raimi, O.G.,Robinson, D.A.,Boldovjakova, D.,Squair, D.R.,Ferenbach, A.T.,Fang, W.,van Aalten, D.M.F.
Targeting a critical step in fungal hexosamine biosynthesis.
J.Biol.Chem., 295:8678-8691, 2020
Cited by
PubMed Abstract: is a human opportunistic fungal pathogen whose cell wall protects it from the extracellular environment including host defenses. Chitin, an essential component of the fungal cell wall, is synthesized from UDP-GlcNAc produced in the hexosamine biosynthetic pathway. As this pathway is critical for fungal cell wall integrity, the hexosamine biosynthesis enzymes represent potential targets of antifungal drugs. Here, we provide genetic and chemical evidence that glucosamine 6-phosphate -acetyltransferase (Gna1), a key enzyme in this pathway, is an exploitable antifungal drug target. deletion resulted in loss of fungal viability and disruption of the cell wall, phenotypes that could be rescued by exogenous GlcNAc, the product of the Gna1 enzyme. In a murine model of aspergillosis, the Δ mutant strain exhibited attenuated virulence. Using a fragment-based approach, we discovered a small heterocyclic scaffold that binds proximal to the Gna1 active site and can be optimized to a selective submicromolar binder. Taken together, we have provided genetic, structural, and chemical evidence that Gna1 is an antifungal target in .
PubMed: 32341126
DOI: 10.1074/jbc.RA120.012985
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.01 Å)
Structure validation

237735

数据于2025-06-18公开中

PDB statisticsPDBj update infoContact PDBjnumon